权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Resident Memory T cells in Leishmaniasis

利什曼病中的常驻记忆 T 细胞

基本信息

批准号：
9916704
负责人：
PHILLIP SCOTT
金额：
$ 40.25万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-05-16 至 2022-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9916704
关键词：
Adjuvant Adoptive Transfer Antigens CD4 Positive T Lymphocytes Cell Differentiation process Cells Cellular Immunity Cutaneous Development Disease Eragrostis Future Generations Genus Mycobacterium Goals Human Immunity Immunization Infection Inflammatory Interferon Type II Interferons Leishmania Leishmania major Leishmaniasis Lesion Link Mediating Memory Methods Mus Nature Parasite Control Parasites Plasmodium Primary Infection Proteins Resistance Resolution Role Route Seeds Skin Skin graft Source T cell differentiation T cell response T memory cell T-Lymphocyte T-Lymphocyte Subsets Testing Toxoplasma Translating Vaccination Vaccines Vaccinia Vaccinia virus cell motility design effector T cell migration monocyte neglected tropical diseases pathogen pathogenic microbe recruit response success tool vaccine development vaccine efficacy vaccine evaluation vaccine-induced immunity

项目摘要

The development of effective vaccines for intracellular microbial pathogens, such as mycobacteria, toxoplasma, plasmodium, and leishmania, remains an elusive goal. Despite substantial efforts to define the mechanisms required for resistance, develop new adjuvants, and identify protective antigens, the long-lived cellular immunity that can be generated in response to infection is not always recapitulated by vaccination. For example, in spite of the strong immunity that develops following an infection with leishmania, efforts to develop a vaccine for human leishmaniasis have been unsuccessful. Lack of success is due in part to the limited understanding of the T cells that mediate protection. While we have identified circulating T cell subsets that contribute to immunity in leishmaniasis (1), these circulating T cells fail to provide the level of immunity observed in mice that have resolved a primary infection with L. major. Using a combination of skin grafting and adoptive transfers, however, we found that leishmania-responsive IFN-γ producing CD4+ T cells resident in the skin are the missing link required for optimal protective immunity (2). We propose to identify how they are generated and maintained in the skin, determine how they promote immunity, and target them in a leishmanial vaccine. These studies are important for leishmaniasis, and have broad implications for vaccine development against other pathogens. In Aim 1 we will define the factors that regulate the accumulation of CD4+ resident memory T cells in the skin following resolution of a primary infection. These studies have direct relevance to vaccine development, as they will define what will be required for generating resident memory T cells. In Aim 2, we focus on the mechanisms by which resident memory T cells mediate protection. Here we will identify the effector T cells that synergize with resident memory T cells to mediate protection, and determine if resident memory T cells help to amplify the generation of T effector cells. Finally, in Aim 3 we will translate this information into an experimental vaccine. We will create a recombinant vaccinia virus expressing a leishmanial antigen, and assess the protection induced by this vaccine and qualitatively and quantitatively define the T cells that contribute to that protection.

开发针对细胞内微生物病原体的有效疫苗，如分枝杆菌，弓形虫、疟原虫和利什曼病仍然是一个难以实现的目标。尽管做出了很大努力来定义抗药性所需的机制，开发新的佐剂，并识别保护性抗原，长寿可对感染作出反应的细胞免疫并不总是通过接种疫苗来实现的。例如，尽管感染利什曼病后产生了强大的免疫力，但努力研制人类利什曼病疫苗一直未获成功。缺乏成功的部分原因是对介导保护的T细胞的了解有限。虽然我们已经确认循环中的T细胞利什曼病中有助于免疫的亚群(1)，这些循环中的T细胞不能提供在已经解决了一次主要感染主要乳杆菌感染的小鼠身上观察到的免疫力。使用蒙皮的组合然而，我们发现，移植和过继转移，利什曼反应性干扰素-γ产生CD_4+T 驻留在皮肤中的细胞是最佳保护性免疫所需的缺失环节。我们建议确定它们是如何在皮肤中产生和维持的，确定它们如何提高免疫力，以及以利什曼病毒疫苗为靶点。这些研究对利什曼病具有重要意义，并具有广泛的应用前景。对针对其他病原体的疫苗开发的影响。在目标1中，我们将定义以下因素调节原发灶消退后CD4+驻留记忆T细胞在皮肤中的积聚感染。这些研究与疫苗开发有直接关系，因为它们将定义生成常驻存储器T细胞所需的。在目标2中，我们重点讨论常驻人员记忆T细胞起到了保护作用。在这里，我们将识别与驻留协同的效应器T细胞记忆T细胞介导保护，并确定驻留的记忆T细胞是否有助于放大 T效应细胞的产生。最后，在目标3中，我们将把这些信息转化为一个实验疫苗。我们将创建一种表达利什曼病毒抗原的重组痘苗病毒，并评估这种疫苗诱导的保护，并定性和定量地定义T细胞对这种保护。